Traditional vs. genetic pathogenesis of arrhythmogenic right ventricular cardiomyopathy

Europace. 2015 Dec;17(12):1770-6. doi: 10.1093/europace/euv042. Epub 2015 Apr 28.

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC), a predominantly familial and autosomal dominant inherited heart muscle disorder, is pathologically characterized by progressive right ventricular myocardial atrophy and fibrofatty replacement and clinically by ventricular arrhythmias with left bundle branch block morphology. Symptoms poorly reflect disease severity, with disease commonly first manifesting as sudden death among the young. The inflammatory and apoptotic theories first put forth to explain ARVC pathogenesis do not explain all cases, and advances in genetic technology have allowed to elucidate genetic mechanisms, with desmosomal mutations attracting much attention. As reviewed here, various non-mutually exclusive pathogenetic mechanisms therefore appear to underlie ARVC.

Keywords: Apoptosis; Arrhythmogenic right ventricular cardiomyopathy; Desmosome; Gene; Inflammation; Pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis* / genetics
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis
  • Arrhythmogenic Right Ventricular Dysplasia / genetics*
  • Arrhythmogenic Right Ventricular Dysplasia / physiopathology
  • DNA Mutational Analysis
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Humans
  • Mutation*
  • Myocarditis / complications*
  • Myocarditis / diagnosis
  • Myocardium / pathology*
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors

Substances

  • Genetic Markers